Literature DB >> 12576409

Lesions of rat skeletal muscle after local block of acetylcholinesterase and neuromuscular stimulation.

S Mense1, D G Simons, U Hoheisel, B Quenzer.   

Abstract

In skeletal muscle, a local increase of acetylcholine (ACh) in a few end plates has been hypothesized to cause the formation of contraction knots that can be found in myofascial trigger points. To test this hypothesis in rats, small amounts of an acetylcholinesterase inhibitor [diisopropylfluorophosphate (DFP)] were injected into the proximal half of the gastrocnemius muscle, and the muscle nerve was electrically stimulated for 30-60 min for induction of muscle twitches. The distal half of the muscle, which performed the same contractions, served as a control to assess the effects of the twitches without DFP. Sections of the muscle were evaluated for morphological changes in relation to the location of blocked end plates. Compared with the distal half of the muscle, the DFP-injected proximal half exhibited significantly higher numbers of abnormally contracted fibers (local contractures), torn fibers, and longitudinal stripes. DFP-injected animals in which the muscle nerve was not stimulated and that were allowed to survive for 24 h exhibited the same lesions but in smaller numbers. The data indicate that an increased concentration of ACh in a few end plates causes damage to muscle fibers. The results support the assumption that a dysfunctional end plate exhibiting increased release of ACh may be the starting point for regional abnormal contractions, which are thought to be essential for the formation of myofascial trigger points.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576409     DOI: 10.1152/japplphysiol.00727.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  21 in total

1.  Chronic refractory myofascial pain and denervation supersensitivity as global public health disease.

Authors:  J Chu; F Bruyninckx; D V Neuhauser
Journal:  BMJ Case Rep       Date:  2016-01-13

Review 2.  The impact of latent trigger points on regional muscle function.

Authors:  Karen R Lucas
Journal:  Curr Pain Headache Rep       Date:  2008-10

3.  Novel applications of ultrasound technology to visualize and characterize myofascial trigger points and surrounding soft tissue.

Authors:  Siddhartha Sikdar; Jay P Shah; Tadesse Gebreab; Ru-Huey Yen; Elizabeth Gilliams; Jerome Danoff; Lynn H Gerber
Journal:  Arch Phys Med Rehabil       Date:  2009-11       Impact factor: 3.966

Review 4.  The role of muscles in tension-type headache.

Authors:  Lars Bendtsen; César Fernández-de-la-Peñas
Journal:  Curr Pain Headache Rep       Date:  2011-12

Review 5.  Evaluation of treatments for myofascial pain syndrome and fibromyalgia.

Authors:  Nathan J Rudin
Journal:  Curr Pain Headache Rep       Date:  2003-12

Review 6.  [Diagnosis and therapy of myofascial trigger points].

Authors:  D G Simons; S Mense
Journal:  Schmerz       Date:  2003-12       Impact factor: 1.107

7.  Neuromuscular damage and repair after dry needling in mice.

Authors:  Ares Domingo; Orlando Mayoral; Sonia Monterde; Manel M Santafé
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-09       Impact factor: 2.629

8.  Treatment of myofascial trigger points in patients with chronic shoulder pain: a randomized, controlled trial.

Authors:  Carel Bron; Arthur de Gast; Jan Dommerholt; Boudewijn Stegenga; Michel Wensing; Rob A B Oostendorp
Journal:  BMC Med       Date:  2011-01-24       Impact factor: 8.775

9.  Probable mechanisms of needling therapies for myofascial pain control.

Authors:  Li-Wei Chou; Mu-Jung Kao; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-31       Impact factor: 2.629

10.  Myofascial trigger points and innervation zone locations in upper trapezius muscles.

Authors:  Marco Barbero; Corrado Cescon; Andrea Tettamanti; Vittorio Leggero; Fiona Macmillan; Fiona Coutts; Roberto Gatti
Journal:  BMC Musculoskelet Disord       Date:  2013-06-08       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.